Abstract
The multidrug-resistance phenotype expressed in mammalian cell lines is complex. Cells selected with a single agent can acquire cross-resistance to a remarkably wide range of compounds which have no obvious structural or functional similarities1–6. The basis for cross-resistance seems to be a decreased net cellular accumulation of the drugs involved, and has been attributed to alterations in the plasma membrane. An over-expressed plasma membrane glycoprotein of relative molecular mass (Mr) 170,000 (P-glycoprotein) is consistently found in different multidrug-resistant human and animal cell lines, and in transplantable tumours1,2,6–10. Consequently, it has been postulated that P-glycoprotein directly or indirectly mediates multidrug resistance7–11. Here we report the cloning of a complementary DNA encoding P-glycoprotein. Southern blot analysis of hamster, mouse and human DNA using this cDNA as a probe showed that P-glycoprotein is conserved and is probably encoded by a gene family, and that members of this putative family are amplified in multidrug-resistant cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Riordan, J. R. & Ling, V. in The International Encyclopedia of Pharmacology and Therapeutics (ed. Goldman, I. D.) (Pergamon, New York, in the press).
Ling, V., Kartner, N., Sudo, T., Siminovitch, L. & Riordan, J. R. Cancer Treat. Rep. 67, 869–874 (1983).
Biedler, J. L., Chang, T., Meyers, M. B., Peterson, R. H. F. & Spengler, B. A. Cancer Treat. Rep. 67, 859–867 (1983).
Beck, W. T. Cancer Treat. Rep. 67, 875–882 (1983).
Curt, G. A., Clendeninn, N. J. & Chabner, B. A. Cancer Treat. Rep. 68, 87–99 (1984).
Kartner, N., Evernden-Porelle, D., Bradley, G. & Ling, V. Nature 316, 820–823 (1985).
Kartner, N., Shales, M., Riordan, J. R. & Ling, V. Cancer Res. 43, 4413–4419 (1983).
Juliano, R. L. & Ling, V. Biochim. biophys. Acta 455, 152–162 (1976).
Kartner, N., Riordan, J. R. & Ling, V. Science 221, 1285–1288 (1983).
Debenham, P. G., Kartner, N., Siminovitch, L., Riordan, J. R. & Ling, V. Molec. cell. Biol. 2, 881–889 (1982).
Robertson, S. M., Ling, V. & Stanners, C. P. Molec. cell. Biol. 4, 500–506 (1984).
Young, R. A. & Davis, R. W. Proc. natn. Acad. Sci. U.S.A. 80, 1194–1198 (1983).
Vieira, J. & Messing, J. Gene 19, 259–268 (1982).
Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N. & Varshavsky, A. Nature 309, 626–628 (1984).
Stark, G. R. & Wahl, G. M. A. Rev. Biochem. 53, 447–491 (1984).
Kopnin, B. P. Cytogenet. Cell Genet. 30, 11–14 (1981).
Baskin, F., Rosenberg, R. N. & Dev, V. Proc. natn. Acad. Sci. U.S.A. 78, 3654–3658 (1981).
Kuo, T., Pathak, S., Ramagli, L., Rodriguez, L. & Hsu, T. C. in Gene Amplification (ed. Schimke, R. T.) 53–57 (Cold Spring Harbor Laboratory, New York, 1982).
Grund, S. H., Patil, S. R., Shah, H. O., Pauw, P. G. & Stadler, J. K. Molec. cell. Biol. 3, 1634–1647 (1983).
Bell, D. R., Gerlach, J. H., Kartner, N., Buick, R. N. & Ling, V. J. din. Oncol. 3, 311–315 (1985).
Ling, V., Gerlach, J. & Kartner, N. Breast Cancer Res. Treat. 4, 89–94 (1984).
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
Aviv, H. & Leder, P. Proc. natn. Acad. Sci. U.S.A. 69, 1408–1412 (1972).
Huynh, T. V., Young, R. A. & Davis, R. W. in Practical Approaches in Biochemistry (ed. Glover, D.) (IRL, Oxford, 1984).
Laemmli, U. K. Nature 227, 680–685 (1970).
Towbin, H., Staehelin, T. & Gordon, J. Proc. natn. Acad. Sci. U.S.A. 76, 4350–4354 (1979).
Thomas, P. S. Meth. Enzym. 100, 255–266 (1983).
Southern, E. M. J. molec. Biol. 98, 503–517 (1975).
Trent, J. M., Olson, S. Lawn, R. M. Proc. natn. Acad. Sci. U.S.A. 79, 7809–7813 (1982).
Schwab, M. et al. Nature 305, 245–248 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riordan, J., Deuchars, K., Kartner, N. et al. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316, 817–819 (1985). https://doi.org/10.1038/316817a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/316817a0
This article is cited by
-
ABCB1 in dermatology: roles in skin diseases and their treatment
Journal of Molecular Medicine (2021)
-
Cancer stem cells and strategies for targeted drug delivery
Drug Delivery and Translational Research (2021)
-
Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance
Molecular Cancer (2019)
-
Dynamics of ABC Transporter P-glycoprotein in Three Conformational States
Scientific Reports (2019)
-
Mechanics and pharmacology of substrate selection and transport by eukaryotic ABC exporters
Nature Structural & Molecular Biology (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.